Endurant Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Endurant Capital Management’s Portfolio PHAS Stock Details PHAS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$322K	Sell
2021 Q4	$940K	Sell
2021 Q3	$3.52M	Sell
2021 Q2	$7.92M	Sell
2021 Q1	$7.49M	Buy